Zhengye Biotechnology Holding Limited
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|
| – | -1.1% | -2.7% | -2.5% | +1.2% | +0.0% | -11.5% | +0.0% | +0.0% | |
| – | +1.2% | -5.2% | -7.7% | -6.4% | +0.0% | -22.6% | +0.0% | +0.0% | |
| – | +141.5% | -36.0% | -52.3% | +158.7% | +0.0% | +170.5% | +0.0% | +0.0% | |
| – | +141.5% | -30.8% | -47.7% | – | – | +159.0% | – | – | |
| – | -7.6% | -19.8% | -7.8% | -35.0% | +48.6% | -79.1% | +0.0% | +0.0% | |
| – | -2.6% | +8.0% | +11.8% | -10.7% | +0.0% | -32.7% | +0.0% | +0.0% | |
| – | -8.5% | -8.5% | +51.0% | -7.5% | +0.0% | +140.4% | +0.0% | +0.0% | |
| – | +15.5% | -14.6% | -14.2% | +2.1% | +0.0% | -7.8% | +0.0% | +0.0% | |
| – | +16.5% | -15.3% | -8.5% | -1.1% | +0.0% | -11.4% | +0.0% | +0.0% | |
| – | +45.5% | +0.0% | +9.4% | – | – | -19.3% | – | – | |
| – | -38.2% | -6.7% | -8.8% | +3.2% | +0.0% | +2.4% | +0.0% | +0.0% | |
| – | – | +0.0% | – | – | -2.1% | – | – | – | |
| – | -11.8% | +4.3% | +3.2% | +0.8% | +0.0% | -12.0% | +0.0% | +0.0% | |
| – | -53.1% | +24.4% | +22.9% | +2.0% | +0.0% | -77.1% | -296.4% | – | |
| – | – | – | +0.0% | +0.0% | +0.5% | +0.0% | +0.0% | +0.0% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.